Citation 81901

PATHAK,V: SHIROTA,O: SEKITA,S: HIRAYAMA,Y: HAKAMATA,Y: HAYASHI,T: YANAGAWA,T: SATAKE,M:. (1997). ANTIANDROGENIC PHENOLIC CONSTITUENTS FROM DALBERGIA COCHINCHINENSIS.. 46(7)

Citation Details

Title	ANTIANDROGENIC PHENOLIC CONSTITUENTS FROM DALBERGIA COCHINCHINENSIS.
Authors	PATHAK,V: SHIROTA,O: SEKITA,S: HIRAYAMA,Y: HAKAMATA,Y: HAYASHI,T: YANAGAWA,T: SATAKE,M:
Year	1997
Volume	46
Issue	7

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Dalbergia cochinchinensis (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	DALBERGIQUINOL,2-HYDROXY-4-5-DIMETHOXY:	None
2	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DALBERGIQUINOL,2-HYDROXY-4-5-DIMETHOXY:	WEAK ACTIVITY
3	TESTOSTERONE(5-ALPHA-DIHYDRO) BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DALBERGIQUINOL,2-HYDROXY-4-5-DIMETHOXY:	WEAK ACTIVITY
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	NEOFLAVENE,6-HYDROXY-2-7-DIMETHOXY:	None
5	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NEOFLAVENE,6-HYDROXY-2-7-DIMETHOXY:	EQUIVOCAL
6	TESTOSTERONE(5-ALPHA-DIHYDRO) BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NEOFLAVENE,6-HYDROXY-2-7-DIMETHOXY:	ACTIVE
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVAN,4'-5-DIHYDROXY-7-METHOXY:	None
8	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN,4'-5-DIHYDROXY-7-METHOXY:	ACTIVE
9	TESTOSTERONE(5-ALPHA-DIHYDRO) BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN,4'-5-DIHYDROXY-7-METHOXY:	ACTIVE
10	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BENZOPHENONE,2-2'-5-TRIHYDROXY-4-METHOXY:	None
11	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPHENONE,2-2'-5-TRIHYDROXY-4-METHOXY:	WEAK ACTIVITY
12	TESTOSTERONE(5-ALPHA-DIHYDRO) BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPHENONE,2-2'-5-TRIHYDROXY-4-METHOXY:	WEAK ACTIVITY
13	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FLAVONE,7-HYDROXY-6-METHOXY:	None
14	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-HYDROXY-6-METHOXY:	WEAK ACTIVITY
15	TESTOSTERONE(5-ALPHA-DIHYDRO) BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-HYDROXY-6-METHOXY:	WEAK ACTIVITY

Show SPARQL Queries (1)